Blog

//Blog

The company, which develops cures for early-onset life-threatening diseases, has emerged from stealth.

Gene-therapy company LogicBio Therapeutics, which develops cures for early-onset life-threatening diseases, has emerged from stealth to announce that it has raised $50 million in a financing round led by Arix Biosciences and with the particvipation of Edmond de Rothschild Investment Partners, Pontifax, and SBI Japan-Israel Innovation Fund. LogicBio also announced that it has relocated it headquarters [...]

By | 2017-07-02T06:08:04+00:00 July 2nd, 2017|Blog|Comments Off on The company, which develops cures for early-onset life-threatening diseases, has emerged from stealth.

Mitoconix Bio hits $20M series A for neurodegenerative R&D

by Ben Adams | Jun 27, 2017 Its tech is based around Stanford's work on mitochondrial function   Preclinical startup Mitoconix Bio has secured a $20 million series A round for its research work on neurological disorders, including its lead candidate for Huntington’s disease. The round was led by Remiges Ventures with help from OrbiMed, Dementia [...]

By | 2017-06-28T08:12:37+00:00 June 28th, 2017|Blog|Comments Off on Mitoconix Bio hits $20M series A for neurodegenerative R&D

Gamida Cell raises $40m

The financing round, led by new investor Shavit Capital, will support Gamida Cell's Phase 3 trial of its NiCord bone marrow transplantation product. Cell and immune therapy technologies company Gamida Cell has announced the signing of a $40 million financing to support the ongoing Phase 3 trial of the its FDA Breakthrough Designated clinical-stage product, [...]

By | 2017-06-20T08:15:04+00:00 June 20th, 2017|Blog|Comments Off on Gamida Cell raises $40m

Israeli Startup Wants to Cure Diabetes by Making Micro-pancreases. It Worked on Mice

Never mind better insulin shots or cell implants for diabetics: Betalin Therapeutics has a unique approach Ruth Schuster Jun 06, 2017 4:22 PM Mice can be cured of diabetes with Prof. Mitrani's micro-pancreas. Credit: Dreamstime.com A young Israeli company that has cured type-1 diabetes in mice and hopes to do the same for humans one [...]

By | 2017-06-07T08:06:22+00:00 June 7th, 2017|Blog|Comments Off on Israeli Startup Wants to Cure Diabetes by Making Micro-pancreases. It Worked on Mice

Lack of infrastructure for later-stage development holds Israeli biotech back

  By Alfred Romann Staff Writer TEL AVIV, Israel – Israel has plenty of innovators and researchers and is pumping out new innovative ideas and research at record speed, but a lack of infrastructure may be holding the industry back and preventing the emergence of companies of global stature. "We are seeing a lot more [...]

By | 2017-05-30T09:35:38+00:00 May 30th, 2017|Blog|Comments Off on Lack of infrastructure for later-stage development holds Israeli biotech back

Israel’s Scopio raises $7 million for digital microscopes

Tel Aviv-based startup develops new way to take and share high-resolution lab slides BY SHOSHANNA SOLOMON May 24, 2017, 5:25 pm Young israelis working on breast cancer research in a Ben-Porath lab in Hadassah university. The lab is trying to understand why certain cancerous cells are able to spread through the body and develop targeted [...]

By | 2017-05-30T09:21:08+00:00 May 30th, 2017|Blog|Comments Off on Israel’s Scopio raises $7 million for digital microscopes

OurCrowd Invests $2.5 Million in Scopio Labs, Brings Total to $80 Million Invested in Healthcare Companies

  OurCrowd, a global leader in equity crowdfunding, today announced that it will invest $2.5 million (as part of a recently completed $7 million investment round) in Scopio Labs, a developer of an advanced digital microscopy and diagnostics platform. This is OurCrowd’s 23rd healthtech investment for a total of $80 million, making OurCrowd the world’s [...]

By | 2017-05-30T09:17:33+00:00 May 30th, 2017|Blog|Comments Off on OurCrowd Invests $2.5 Million in Scopio Labs, Brings Total to $80 Million Invested in Healthcare Companies